Per Walday

Per Walday has 30+ years’ experience developing pharmaceuticals from early preclinical to commercialisation. Previously, he was the CEO of PCI Biotech, managing development of drug-device combinations through FDA and EMA regulatory paths to late-stage development. His earlier positions include Global Head of Project Management GE Healthcare, with responsibility for all development programmes of new pharmaceuticals.